Playlist


Ashgabat to host eco-festival focused on environmental awareness and sustainability
26 Jun. 11:33The "Yash Tebigatchy" (Young Naturalist) public organization is launching a major environmental initiative in Turkmenistan's capital titled "Together to a Green Future!". This upcoming event aims to promote ecological culture among urban residents, foster sustainable habits, and raise public awareness regarding the critical importance of environmental preservation in modern society.
The organizers have scheduled a diverse and engaging educational program suitable for attendees of all generations. The event venue will feature specialized STEM learning stations, interactive environmental games, and hands-on creative workshops conducted by experts. To enhance the overall visitor experience, the festival grounds will be accompanied by continuous live music performances throughout the day.
A core practical element of the festival involves encouraging waste reduction and promoting the principles of a circular economy. Visitors are invited to contribute to global conservation efforts by bringing recyclable plastic bottles or pre-owned garments for a dedicated clothing swap counter. Participants who show exceptional engagement in these green initiatives will receive special promotional gifts from the hosts and corporate sponsors.
The public gathering is scheduled for July 4, 2026, running from 16:00 to 19:00. The hosting venue is the "Bilelik Hub" creative space, situated on the 1st floor of Block C within the "Ashgabat" Shopping and Entertainment Center. For registration details and general inquiries, interested individuals may call +(993 64) 26-84-32, visit the official website at tebigatchy.co.tm, or follow the community updates on social media.


Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds
Today in 02:02Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.
Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.